Literature DB >> 1348169

Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation.

S L Ollerenshaw1, A J Woolcock.   

Abstract

Although the characteristics of the histopathologic changes present in subjects who die with status asthmaticus are well documented, the structural changes present in subjects with mild to moderately severe asthma are not well described and the inflammatory changes in the large airways of subjects with chronic airflow limitation (CAL) and asthma have not been compared. Ten subjects with asthma, five taking inhaled corticosteroids and five taking beta 2-agonist aerosols, five subjects with CAL, and four subjects with no respiratory illness had four biopsies taken from airways 10 mm in diameter. The length of intact epithelium, thickness of basement membrane, and number of lymphocytes, neutrophils, eosinophils, plasma cells, monocytes, and mast cells in the lamina propria, bronchial smooth muscle, and submucosa were measured. Intact epithelium was present along 56% of the basement membrane in the asthmatic subjects, along 54% in the subjects with CAL, and along 84% in the control subjects. In the asthmatic subjects there was no direct relationship between the severity of asthma and the amount of epithelial cell loss or the number of inflammatory cells. The basement membrane was thickened in all asthmatic subjects but not in normal subjects or subjects with CAL. There was a significant increase in the number of lymphocytes, eosinophils, and mast cells in the asthmatic airways, particularly in the lamina propria, compared with the CAL subjects. There were no eosinophils or mast cells in any of the control subjects. The airways of subjects with CAL contained significantly more inflammatory cells than the control subjects. Subjects with asthma on inhaled corticosteroids had significantly fewer lymphocytes, eosinophils, and mast cells compared with subjects taking only beta 2-agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348169     DOI: 10.1164/ajrccm/145.4_Pt_1.922

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

Review 1.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Variability of inflammatory cell counts on bronchial biopsies of normal subjects.

Authors:  H Turcotte; M Laviolette; M Boutet; L-P Boulet
Journal:  Lung       Date:  2003       Impact factor: 2.584

Review 3.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

4.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  Impaired reflex responses to airway occlusion in the inspiratory muscles of asthmatic subjects.

Authors:  J E Butler; D K McKenzie; S C Gandevia
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

6.  Sinus and adenoid inflammation in children with chronic rhinosinusitis and asthma.

Authors:  Antony Anfuso; Hassan Ramadan; Andrew Terrell; Yesim Demirdag; Cheryl Walton; David P Skoner; Giovanni Piedimonte
Journal:  Ann Allergy Asthma Immunol       Date:  2015-02       Impact factor: 6.347

7.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.

Authors:  D Stănescu; A Sanna; C Veriter; S Kostianev; P G Calcagni; L M Fabbri; P Maestrelli
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

8.  Effects of dexamethasone on airway hyper-responsiveness to the adenosine A1 receptor agonist cyclo-pentyl adenosine in an allergic rabbit model.

Authors:  A Z El-Hashim; K H Banner; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

9.  Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease.

Authors:  J W de Jong; D S Postma; T W van der Mark; G H Koëter
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

10.  Reticular basement membrane in asthma and COPD: similar thickness, yet different composition.

Authors:  Jeroen J W Liesker; Nick H Ten Hacken; Mieke Zeinstra-Smith; Steven R Rutgers; Dirkje S Postma; Wim Timens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.